Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Autophagic Flux
25%
Autophagy
100%
Autophagy Markers
25%
Beta-catenin
100%
Cancer Stem Cells
25%
Cancer Types
25%
CD133
50%
Cell Growth
25%
Challenging Issues
25%
Chemotherapy Resistance
25%
Clinical Setting
25%
Concurrent Chemoradiotherapy
25%
Fractionated Radiation
25%
Glioblastoma
100%
Glioblastoma multiforme
75%
Ionizing Radiation
100%
LC3-II
75%
Lines of Evidence
25%
Local Recurrence
25%
MG132
25%
Molecular Mechanism
25%
Nestin
50%
New Therapeutic Approaches
25%
Overall Survival
25%
Pharmacological Inhibitors
25%
Protease Inhibitors
25%
Radiation Chemotherapy
25%
Radiation Field
25%
Radioresistance
50%
Recurrent Glioblastoma multiforme
25%
Resistant Cells
25%
Sex-determining Region Y-box 2 (SOX2)
25%
Stem Cell Markers
50%
Stem Cells
100%
Therapy Resistance
25%
Therapy-resistant
25%
Two-level
25%
U87MG
25%
Pharmacology, Toxicology and Pharmaceutical Science
Benzyloxycarbonylleucylleucylleucinal
20%
Catenin
100%
Chemoradiation Therapy
20%
Chemotherapy Regimens
20%
Glioblastoma
100%
Ionizing Radiation
100%
Malignant Neoplasm
40%
Nestin
40%
Overall Survival
20%
Proteasome Inhibitor
20%
Recurrent Disease
20%
Therapy Resistance
20%
Neuroscience
Autophagy
100%
Cancer Stem Cell
16%
Catenin
100%
CD133
33%
CD44
16%
Cell Growth
16%
Chemotherapy
16%
Glioblastoma Multiforme
66%
Nestin
33%
Proteasome Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Cancer Stem Cell
16%
Catenin
100%
CD133
33%
CD44
16%
Cell Growth
16%
MG132
16%
Molecular Mechanism
16%
Overall Survival
16%
Proteasome Inhibitor
16%
Radiation Field
16%
Radiosensitivity
33%